MERIDIAN BIOSCIENCE, INC. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 9 rows in 2014. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2014-12-01: Reporting owner ROLIH SUSAN; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-11-18: Reporting owner KRAEUTLER JOHN A; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-11-18: Reporting owner LUEKE MELISSA; Form 4; Security Stock Options (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2014-07-22: Reporting owner Ellingwood Dwight E; Form 4; Security Stock Options (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2014-12-01 | ROLIH SUSAN Officer (EVP, Reg & Quality Systems) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,750 0 owned after | $7.28 exercise price | 2014-12-02 | |
| 2014-11-18 | KRAEUTLER JOHN A Director, Officer (Chairman and CEO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,500 0 owned after | $7.28 exercise price | 2014-11-20 | |
| 2014-11-18 | LUEKE MELISSA Officer (Exec VP, CFO) | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −10,500 0 owned after | $7.28 exercise price | 2014-11-20 | |
| 2014-07-22 | Ellingwood Dwight E Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $20.80 exercise price | 2014-07-24 | |
| 2014-04-25 holding as of filing | Shaughnessy Michael C. Officer (EVP, Pres Meridian Global Dx) | 3 | Stock Options (Right to Buy) Derivative · Direct | Holding | $21.34 exercise price | 2014-04-25 | ||
| 2014-01-22 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $25.83 exercise price | 2014-01-23 | |
| 2014-01-22 | PHILLIPS DAVID Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $25.83 exercise price | 2014-01-23 | |
| 2014-01-22 | Anderson James M. Director | 4 | Stock Options (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +8,500 8,500 owned after | $25.83 exercise price | 2014-01-23 | |
| 2014-01-03 | READY ROBERT J Director | 4 | Stock Options (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −5,214 0 owned after | $5.35 exercise price | 2014-01-07 |